SLC16A1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.62447832963153E-12 |
Normal-vs-Stage2 |
6.80659972829289E-11 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
<1E-12 |
Stage1-vs-Stage2 |
7.940800E-01 |
Stage1-vs-Stage3 |
2.798600E-01 |
Stage1-vs-Stage4 |
1.766420E-01 |
Stage2-vs-Stage3 |
5.706000E-01 |
Stage2-vs-Stage4 |
4.978400E-01 |
Stage3-vs-Stage4 |
9.556000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62436730732907E-12 |
Normal-vs-AfricanAmerican |
1.66533453693773E-15 |
Normal-vs-Asian |
1.022270E-02 |
Caucasian-vs-AfricanAmerican |
6.546300E-02 |
Caucasian-vs-Asian |
9.013600E-01 |
AfricanAmerican-vs-Asian |
5.877200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62447832963153E-12 |
Normal-vs-Female |
<1E-12 |
Male-vs-Female |
2.313600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.41609999999515E-05 |
Normal-vs-Age(41-60Yrs) |
<1E-12 |
Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
Normal-vs-Age(81-100Yrs) |
1.35119999966626E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.623600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.263000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.577750E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.090370E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.650400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.371800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.87569999996218E-06 |
Normal-vs-Grade 2 |
<1E-12 |
Normal-vs-Grade 3 |
1.62436730732907E-12 |
Normal-vs-Grade 4 |
<1E-12 |
Grade 1-vs-Grade 2 |
8.498200E-01 |
Grade 1-vs-Grade 3 |
2.521200E-01 |
Grade 1-vs-Grade 4 |
4.708800E-01 |
Grade 2-vs-Grade 3 |
3.185700E-02 |
Grade 2-vs-Grade 4 |
1.864830E-01 |
Grade 3-vs-Grade 4 |
5.564600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62436730732907E-12 |
Normal-vs-ccB subtype |
1.11022302462516E-16 |
ccA subtype-vs-ccB subtype |
2.928600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62447832963153E-12 |
Normal-vs-N1 |
1.538490E-03 |
N0-vs-N1 |
3.794800E-01 |
|
|